Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).

Murray, Macey L; Meadows, Jade; Doré, Caroline J; Copas, Andrew J; Haddow, Lewis J; Lacey, Charles; Jit, Mark; Soldan, Kate; Bennett, Kate; Tetlow, Michelle; +2 more... Nathan, Mayura; Gilson, Richard; (2018) Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial). BMC medical research methodology, 18 (1). 125-. ISSN 1471-2288 DOI: https://doi.org/10.1186/s12874-018-0581-z

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/s12874-018-0581-z

Abstract

Share

Download

Filename: Human-papillomavirus-infection.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar